Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JUNO THERAPEUTICS INC

 SummaryNewsCompany 
Company
More about the company
All news about JUNO THERAPEUTICS INC
2018Merits of any Takeda bid for Shire questioned, shares slide
RE
2018Merits of any Takeda bid for Shire questioned, shares slide
RE
2018Drugmaker Shire soars as Japan's Takeda considers bid
RE
2018Sangamo in $3 billion gene-editing deal with Gilead
RE
2018JUNO THERAPEUTICS : Celgene Receives Antitrust Clearance for Juno Acquisition
BU
2018Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
RE
2018THE LAW OFFICES OF VINCENT WONG : Reminds Investors of an Investigation of Juno Therapeuti..
BU
2018THE LAW OFFICES OF VINCENT WONG : Notifies Investors of an Investigation of Juno Therapeut..
BU
2018WEISSLAW LLP : Investigates Juno Therapeutics Inc. Acquisition
PR
2018Rigrodsky & Long, P.A. Announces Investigation of Juno Therapeutics, Inc. Buyout
BU
2018Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale..
BU
2018Stocks hit record as senators reach deal to end shutdown
RE
2018Monteverde & Associates PC Launches An Investigation of the Board of Directors and Offi..
PR
2018JUNO THERAPEUTICS, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by ..
BU
2018ALERT : Rowley Law PLLC is Investigating Proposed Acquisition of Juno Therapeutics, Inc.
PR
More news
News in other languages on JUNO THERAPEUTICS INC
2018Sanofi s'offre une nouvelle biotech en achetant Ablynx 3,9 milliards d'euros
2018ORIGINAL-RESEARCH : Medigene AG (von EQUITS GmbH): Kaufen
2018Wall Street finit en hausse, accord sur le "shutdown"
2018BOURSE : Wall Street finit à des records après l'accord au Sénat mettant fin au "shutdown"
2018Les Bourses européennes clôturent en hausse, le M&A éclipse le "shutdown"
More news
Analyst Recommendations on JUNO THERAPEUTICS INC
More recommendations
Managers and Directors
Mark J. Gilbert Chief Medical Officer & Senior Vice President
Ann L. Lee Executive Vice President-Technical Operations
Mark J. Alles Director
Peter N. Kellogg Director
Nicole Keith Investor Relations Contact
Sector and Competitors
1st jan.Capi. (M$)
JUNO THERAPEUTICS INC90.24%0
GILEAD SCIENCES, INC.22.19%89 259
BIONTECH SE309.08%80 542
WUXI APPTEC CO., LTD.34.39%68 685
REGENERON PHARMACEUTICALS32.25%66 425
VERTEX PHARMACEUTICALS-22.31%47 634